BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1344459)

  • 1. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
    Gerc V; Koblar V; Brkić D; Kamhi J
    Med Pregl; 1992; 45(7-8):285-7. PubMed ID: 1344459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
    Okrucká A; Pechán J; Mikulecký M
    Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
    Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.
    Muravyov AV; Meiselman HJ; Yakusevich VV; Zamishlayev AV
    Clin Hemorheol Microcirc; 2002; 26(2):125-35. PubMed ID: 12082261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diuretics on red blood cell microrheological parameters in female hypertensive patients.
    Muravyov AV; Yakusevich VV; Kabanov AV; Petrochenko AS
    Clin Hemorheol Microcirc; 2005; 33(2):121-6. PubMed ID: 16151259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorheological background of acetylsalicylic acid resistance.
    Feher G; Koltai K; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
    Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prazosin GITS, atenolol, nifedipine SR, and enalapril on ADP-induced platelet aggregation.
    Patki KC; Joglekar SJ; Kamat SK; Thatte UM; Yeolekar ME; Rege NN; Dahanukar SA; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():26-9. PubMed ID: 11229106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclodextrins on RBC aggregation and blood viscosity.
    Toyama Y; Pais E; Meiselman HJ; Alexy T
    Clin Hemorheol Microcirc; 2007; 36(2):173-80. PubMed ID: 17325441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.
    Cecchi E; Marcucci R; Paniccia R; Bandinelli B; Valente S; Giglioli C; Lazzeri C; Gensini GF; Abbate R; Mannini L
    Am J Cardiol; 2009 Sep; 104(6):764-8. PubMed ID: 19733708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prazosin therapy on platelet activation in essential hypertension.
    Okrucká A; Pechán J; Mikulecký M
    Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
    Vekasi J; Koltai K; Gaal V; Toth A; Juricskay I; Kesmarky G
    Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
    Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
    Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in blood viscosity accompanying the response to prazosin in patients with essential hypertension.
    Letcher RL; Chien S; Laragh JH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S8-20. PubMed ID: 94641
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension.
    Martínez M; Vayá A; Labios M; Gabriel F; Guiral V; Aznar J
    Clin Hemorheol Microcirc; 1997; 17(3):193-8. PubMed ID: 9356783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.